ArticleBMC veterinary research2025
Clinical evaluation of a functional diet containing Siraitia grosvenorii residual extract for atopic dermatitis in dogs: a self-controlled study.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Oral Administration ofAnimals : an open access journal from MDPI · 2026Article
- Plant-Derived Functional Ingredients in Pet Nutrition: Phytochemical Classification, Mechanisms, Efficacy, and Application in Dogs and Cats.Animals : an open access journal from MDPI · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundCanine atopic dermatitis (CAD) is a chronic inflammatory skin disease that significantly impairs quality of life. Nutritional interventions have gained attention as supportive therapeutic strategies. This study investigated the clinical efficacy and safety of a functional diet containing Siraitia grosvenorii residual extract by evaluating its effects on clinical symptoms and inflammatory markers in dogs with CAD using a self-controlled design.
methodsA total of 32 dogs diagnosed with CAD were fed a standard diet for 12 weeks (control phase) followed by a functional diet for 12 weeks (treatment phase). Clinical assessments, including transepidermal water loss (TEWL), Canine Atopic Dermatitis Extent and Severity Index (CADESI-04), Pruritus Visual Analog Scale (PVAS), Owner Global Assessment of Treatment Efficacy (OGATE), and serum IgE levels were conducted at baseline and at 6-week intervals.
resultsTEWL, CADESI-04, and PVAS scores significantly improved during the treatment phase compared with the control phase (p = 0.0002, < 0.0001, and < 0.0001, respectively). No significant difference was observed in serum in serum IgE levels (p = 0.8046). The OGATE responses indicated 80.65% rate of owner-reported satisfaction.
conclusionsThe functional diet significantly improved the clinical signs of CAD and was well tolerated. These findings suggest that nutritional support with the Siraitia grosvenorii extract may be a beneficial adjunctive therapy for CAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.